Boston Common Asset Management’s Advantest Corp ATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.75M Buy
32,439
+639
+2% +$133K 0.4% 74
2026
Q1
$4.32M Sell
31,800
-8,281
-21% -$1.12M 0.28% 94
2025
Q4
$5.02M Sell
40,081
-11,407
-22% -$1.43M 0.3% 85
2025
Q3
$5.11M Buy
51,488
+2,496
+5% +$248K 0.14% 187
2025
Q2
$3.61M Buy
+48,992
New +$3.61M 0.1% 218

Other funds holding ATE

Boston Common Asset Management's ATE Position: Q2 2026 in Review

Boston Common Asset Management increased its Advantest Corp (ATE) stake by 2% in Q2 2026, buying an estimated $133K and bringing the position to 32,439 shares worth $6.75M. The position accounts for 0.4% of the portfolio, ranked #74.

Boston Common Asset Management first reported a position in ATE in Q2 2025 and has held it in 5 quarters since. 11 funds tracked by Wall St. Rank hold ATE as of Q2 2026.

  • Boston Common Asset Management held 32,439 shares of Advantest Corp worth $6.75M as of Q2 2026.
  • Boston Common Asset Management bought 639 Advantest Corp shares in Q2 2026, an estimated $133K.
  • Advantest Corp made up 0.4% of Boston Common Asset Management's portfolio in Q2 2026, its #74 holding.
  • Boston Common Asset Management first reported a position in Advantest Corp in Q2 2025 and has held it in 5 quarters since.
  • 11 funds tracked by Wall St. Rank held Advantest Corp as of Q2 2026.

Based on Boston Common Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.